PROCTER & GAMBLE HEALTH | GANGA PHARMACEUTICALS | PROCTER & GAMBLE HEALTH/ GANGA PHARMACEUTICALS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.4 | - | - | View Chart |
P/BV | x | 10.5 | 2.1 | 503.2% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH GANGA PHARMACEUTICALS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
GANGA PHARMACEUTICALS Mar-23 |
PROCTER & GAMBLE HEALTH/ GANGA PHARMACEUTICALS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 15 | 35,069.3% | |
Low | Rs | 3,883 | 8 | 49,782.1% | |
Sales per share (Unadj.) | Rs | 740.7 | 6.4 | 11,629.5% | |
Earnings per share (Unadj.) | Rs | 138.2 | 0.1 | 143,906.1% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 0.2 | 65,620.9% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 13.4 | 3,334.6% | |
Shares outstanding (eoy) | m | 16.60 | 4.06 | 408.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.8 | 344.2% | |
Avg P/E ratio | x | 33.5 | 119.5 | 28.0% | |
P/CF ratio (eoy) | x | 29.8 | 49.1 | 60.7% | |
Price / Book Value ratio | x | 10.3 | 0.9 | 1,200.2% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 47 | 163,633.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 0 | 502,853.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 26 | 47,549.1% | |
Other income | Rs m | 184 | 3 | 6,171.1% | |
Total revenues | Rs m | 12,480 | 29 | 43,258.6% | |
Gross profit | Rs m | 3,247 | 0 | 6,493,600.0% | |
Depreciation | Rs m | 281 | 1 | 50,178.6% | |
Interest | Rs m | 8 | 2 | 396.9% | |
Profit before tax | Rs m | 3,142 | 1 | 592,830.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 0 | 605,214.3% | |
Profit after tax | Rs m | 2,295 | 0 | 588,384.6% | |
Gross profit margin | % | 26.4 | 0.2 | 14,436.2% | |
Effective tax rate | % | 27.0 | 26.1 | 103.5% | |
Net profit margin | % | 18.7 | 1.5 | 1,227.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 51 | 22,756.6% | |
Current liabilities | Rs m | 6,791 | 19 | 35,835.4% | |
Net working cap to sales | % | 40.0 | 125.8 | 31.8% | |
Current ratio | x | 1.7 | 2.7 | 63.5% | |
Inventory Days | Days | 263 | 310 | 84.7% | |
Debtors Days | Days | 343 | 125,511 | 0.3% | |
Net fixed assets | Rs m | 10,617 | 28 | 37,423.0% | |
Share capital | Rs m | 166 | 41 | 408.7% | |
"Free" reserves | Rs m | 7,265 | 14 | 52,300.2% | |
Net worth | Rs m | 7,431 | 55 | 13,633.9% | |
Long term debt | Rs m | 0 | 6 | 0.0% | |
Total assets | Rs m | 22,330 | 80 | 27,968.1% | |
Interest coverage | x | 409.1 | 1.3 | 32,128.0% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.3 | 170.0% | |
Return on assets | % | 10.3 | 2.9 | 353.5% | |
Return on equity | % | 30.9 | 0.7 | 4,281.6% | |
Return on capital | % | 42.4 | 4.1 | 1,045.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 0 | - | |
Fx outflow | Rs m | 1,605 | 0 | - | |
Net fx | Rs m | -140 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 0 | -590,000.0% | |
From Investments | Rs m | -215 | 5 | -4,369.9% | |
From Financial Activity | Rs m | -985 | -4 | 22,177.9% | |
Net Cashflow | Rs m | 1,160 | 0 | 1,289,222.2% |
Indian Promoters | % | 0.0 | 56.0 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | - | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 44.0 | 109.5% | |
Shareholders | 56,778 | 362 | 15,684.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | GANGA PHARMACEUTICALS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.10% | 0.00% | -0.44% |
1-Month | -3.40% | 0.00% | 2.15% |
1-Year | -0.21% | 80.77% | 49.82% |
3-Year CAGR | -9.53% | 57.63% | 14.21% |
5-Year CAGR | 4.45% | 31.40% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the GANGA PHARMACEUTICALS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of GANGA PHARMACEUTICALS the stake stands at 56.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of GANGA PHARMACEUTICALS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
GANGA PHARMACEUTICALS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of GANGA PHARMACEUTICALS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.